Language
新冠病毒,新冠,动物实验
z-bo
2020-07-17
767
Suvit Maesincee, Minister of Higher Education, Science, Research and Innovation of Thailand, said that human trials of the covid-19 vaccine will begin as early as October.
Minister Maesincee revealed that the test results of the new crown vaccine previously carried out on monkeys were encouraging. He said at a press conference: "After the first injection of monkeys with an mRNA vaccine, all monkeys remained healthy and had no side effects. They also found an increase in the amount of antibodies in their blood."
Vaccines are jointly developed by various medical and viral disease experts from Chulalongkorn University, the National Institute of Vaccine and Medical College of Thailand. The researchers used mRNA technology to decode the blueprint of important coronavirus building proteins.
Maesincee Minister added: "We are using mRNA technology, which is the latest method of developing vaccines, which can quickly develop vaccines and can be tested in small quantities."
The National Research Council of Thailand also supports the development of vaccines and allocated funds to Chulalongkorn University to prepare for the production of vaccines for human testing.
Thai Prime Minister Pak Yu also ensured that before the vaccines are provided and supplied to other countries, Thais will be the first beneficiaries of the upcoming vaccines. The minister explained: “Prime Minister Yukuba has established a policy to ensure that after the vaccine is successfully developed, it is first supplied to Thais before being provided to foreign countries.”
also added that the research department expects the second round of animal vaccine trials to start in August. If the test is successful, human trials will be conducted in October.